Because the expression of ERG in prostate tumor tissue is primarily driven by the TMPRSS2–ERG fusion event (135), we inferred the ERG fusion status based on the expression level of the ERG gene (Fig. 8A). This evidence concerns the gene TMPRSS2 and prostate neoplasm.